Cargando…

Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma

The histopathological and molecular heterogeneity of glioblastomas represents a major obstacle for effective therapies. Glioblastomas do not develop autonomously, but evolve in a unique environment that adapts to the growing tumour mass and contributes to the malignancy of these neoplasms. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bougnaud, Sébastien, Golebiewska, Anna, Oudin, Anaïs, Keunen, Olivier, Harter, Patrick N., Mäder, Lisa, Azuaje, Francisco, Fritah, Sabrina, Stieber, Daniel, Kaoma, Tony, Vallar, Laurent, Brons, Nicolaas H.C., Daubon, Thomas, Miletic, Hrvoje, Sundstrøm, Terje, Herold-Mende, Christel, Mittelbronn, Michel, Bjerkvig, Rolf, Niclou, Simone P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077988/ https://www.ncbi.nlm.nih.gov/pubmed/27049916 http://dx.doi.org/10.18632/oncotarget.7454

Ejemplares similares

Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells
por: Golebiewska, Anna, et al.
Publicado: (2013)

Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes
por: Stieber, Daniel, et al.
Publicado: (2013)

Comprehensive Analysis of Glycolytic Enzymes as Therapeutic Targets in the Treatment of Glioblastoma
por: Sanzey, Morgane, et al.
Publicado: (2015)

Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
por: Fack, Fred, et al.
Publicado: (2014)

Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment
por: Dirkse, Anne, et al.
Publicado: (2019)

Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology
por: Golebiewska, Anna, et al.
Publicado: (2020)

Databases for lncRNAs: a comparative evaluation of emerging tools
por: Fritah, Sabrina, et al.
Publicado: (2014)

Temozolomide-Induced RNA Interactome Uncovers Novel LncRNA Regulatory Loops in Glioblastoma
por: Fritah, Sabrina, et al.
Publicado: (2020)

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
por: Johansson, Mikael, et al.
Publicado: (2013)

Altered metabolic landscape in IDH‐mutant gliomas affects phospholipid, energy, and oxidative stress pathways
por: Fack, Fred, et al.
Publicado: (2017)

In vivo models of primary brain tumors: pitfalls and perspectives
por: Huszthy, Peter C., et al.
Publicado: (2012)

Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM)
por: Demeure, Kevin, et al.
Publicado: (2016)

Hub genes in a pan-cancer co-expression network show potential for predicting drug responses
por: Azuaje, Francisco, et al.
Publicado: (2019)

iTRAQ-based Proteomics Profiling Reveals Increased Metabolic Activity and Cellular Cross-talk in Angiogenic Compared with Invasive Glioblastoma Phenotype
por: Rajcevic, Uros, et al.
Publicado: (2009)

A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1
por: Klink, Barbara, et al.
Publicado: (2013)

Correction: A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1
por: Klink, Barbara, et al.
Publicado: (2013)

Expansive growth of two glioblastoma stem-like cell lines is mediated by bFGF and not by EGF
por: Podergajs, Neza, et al.
Publicado: (2013)

Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors
por: Oudin, Anaïs, et al.
Publicado: (2021)

Tumor versus Stromal Cells in Culture—Survival of the Fittest?
por: Talasila, Krishna M., et al.
Publicado: (2013)

Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A
por: Abdul Rahim, Siti Aminah, et al.
Publicado: (2017)

U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells
por: Torsvik, Anja, et al.
Publicado: (2014)

Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
por: Klein, Eliane, et al.
Publicado: (2020)

Single‐cell transcriptomics reveals distinct inflammation‐induced microglia signatures
por: Sousa, Carole, et al.
Publicado: (2018)

Glutamine Synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma
por: Tardito, Saverio, et al.
Publicado: (2015)

Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells
por: Podergajs, Neža, et al.
Publicado: (2015)

THER-11. PEPTIDE-MEDIATED PERMEABILIZATION OF THE BLOOD-BRAIN BARRIER IMPROVES DRUG DELIVERY TO BRAIN METASTASIS
por: Aasen, Synnøve Nymark, et al.
Publicado: (2019)

AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion
por: Schuster, Anne, et al.
Publicado: (2020)

FSMP-07. CYSTATHIONINE-Γ-LYASE DRIVES ANTIOXIDANT DEFENSE IN CYSTEINE-RESTRICTED IDH1 MUTANT ASTROCYTOMAS
por: Cano-Galiano, Andrés, et al.
Publicado: (2021)

EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis
por: Talasila, Krishna M., et al.
Publicado: (2013)

Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects
por: Hossain, Jubayer A, et al.
Publicado: (2020)

Cystathionine-γ-lyase drives antioxidant defense in cysteine-restricted IDH1-mutant astrocytomas
por: Cano-Galiano, Andrés, et al.
Publicado: (2021)

EGFL7 enhances surface expression of integrin α(5)β(1) to promote angiogenesis in malignant brain tumors
por: Dudvarski Stanković, Nevenka, et al.
Publicado: (2018)

Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling
por: Han, Mingzhi, et al.
Publicado: (2020)

OECI-EACR precision medicine for cancer: Conference report 1–4 March 2015, Luxembourg
por: Golebiewska, Anna, et al.
Publicado: (2015)

Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
por: Kulkarni, Amit, et al.
Publicado: (2021)

Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma
por: Han, Mingzhi, et al.
Publicado: (2019)

A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions
por: Niclou, Simone P., et al.
Publicado: (2008)

Impact of IDH Mutations, the 1p/19q Co-Deletion and the G-CIMP Status on Alternative Splicing in Diffuse Gliomas
por: Zhang, Lu, et al.
Publicado: (2023)

Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma
por: Azuaje, Francisco, et al.
Publicado: (2015)

Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression
por: Huszthy, Peter C., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tpv4s3i30u3hj8fi26pn7kt6k6